# Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders

> **NCT01832597** · — · COMPLETED · sponsor: **Gruppo Italiano Studio Linfomi** · enrollment: 109 (actual)

## Conditions studied

- Chronic Lymphocytic Leukaemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01832597
- **Lead sponsor:** Gruppo Italiano Studio Linfomi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2013-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832597, "Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01832597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*